FR2688785B1 - Sequence peptidique apte a induire une reaction d'hypersensibilite de type retarde en presence de bacteries vivantes du complexe mycobacterium tuberculosis, et ses applications. - Google Patents

Sequence peptidique apte a induire une reaction d'hypersensibilite de type retarde en presence de bacteries vivantes du complexe mycobacterium tuberculosis, et ses applications.

Info

Publication number
FR2688785B1
FR2688785B1 FR9203286A FR9203286A FR2688785B1 FR 2688785 B1 FR2688785 B1 FR 2688785B1 FR 9203286 A FR9203286 A FR 9203286A FR 9203286 A FR9203286 A FR 9203286A FR 2688785 B1 FR2688785 B1 FR 2688785B1
Authority
FR
France
Prior art keywords
inducing
applications
peptide sequence
mycobacterium tuberculosis
sequence capable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9203286A
Other languages
English (en)
Other versions
FR2688785A1 (fr
Inventor
Marchal Gilles
Romain Felix
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur de Lille
Original Assignee
Institut Pasteur de Lille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur de Lille filed Critical Institut Pasteur de Lille
Priority to FR9203286A priority Critical patent/FR2688785B1/fr
Priority to PCT/FR1993/000268 priority patent/WO1993019093A1/fr
Priority to US08/302,771 priority patent/US5599541A/en
Priority to CA002132218A priority patent/CA2132218A1/fr
Priority to EP93920549A priority patent/EP0632816A1/fr
Publication of FR2688785A1 publication Critical patent/FR2688785A1/fr
Application granted granted Critical
Publication of FR2688785B1 publication Critical patent/FR2688785B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/5695—Mycobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Physiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FR9203286A 1992-03-19 1992-03-19 Sequence peptidique apte a induire une reaction d'hypersensibilite de type retarde en presence de bacteries vivantes du complexe mycobacterium tuberculosis, et ses applications. Expired - Fee Related FR2688785B1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR9203286A FR2688785B1 (fr) 1992-03-19 1992-03-19 Sequence peptidique apte a induire une reaction d'hypersensibilite de type retarde en presence de bacteries vivantes du complexe mycobacterium tuberculosis, et ses applications.
PCT/FR1993/000268 WO1993019093A1 (fr) 1992-03-19 1993-03-17 Sequence peptidique apte a induire une reaction d'hypersensibilite de type retarde en presence de bacteries vivantes du complexe mycobacterium tuberculosis et ses applications
US08/302,771 US5599541A (en) 1992-03-19 1993-03-17 Peptide sequence capable of inducing a delayed-type hypersensitivity reaction in the presence of living bacteria of the Mycobacterium tuberculosis complex and its applications
CA002132218A CA2132218A1 (fr) 1992-03-19 1993-03-17 Sequence peptidique apte a induire une reaction d'hypersensibilite de type retarde en presence de bacteries vivantes du complexe mycobacterium tuberculosis et ses applications
EP93920549A EP0632816A1 (fr) 1992-03-19 1993-03-17 SEQUENCE PEPTIDIQUE APTE A INDUIRE UNE REACTION D'HYPERSENSIBILITE DE TYPE RETARDE EN PRESENCE DE BACTERIES VIVANTES DU COMPLEXE $i(MYCOBACTERIUM TUBERCULOSIS) ET SES APPLICATIONS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9203286A FR2688785B1 (fr) 1992-03-19 1992-03-19 Sequence peptidique apte a induire une reaction d'hypersensibilite de type retarde en presence de bacteries vivantes du complexe mycobacterium tuberculosis, et ses applications.

Publications (2)

Publication Number Publication Date
FR2688785A1 FR2688785A1 (fr) 1993-09-24
FR2688785B1 true FR2688785B1 (fr) 1995-07-07

Family

ID=9427830

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9203286A Expired - Fee Related FR2688785B1 (fr) 1992-03-19 1992-03-19 Sequence peptidique apte a induire une reaction d'hypersensibilite de type retarde en presence de bacteries vivantes du complexe mycobacterium tuberculosis, et ses applications.

Country Status (5)

Country Link
US (1) US5599541A (fr)
EP (1) EP0632816A1 (fr)
CA (1) CA2132218A1 (fr)
FR (1) FR2688785B1 (fr)
WO (1) WO1993019093A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2677365B1 (fr) * 1991-06-07 1995-08-04 Pasteur Institut Proteines de mycobacterium et applications.
US6752993B1 (en) 1993-11-23 2004-06-22 The Regents Of The University Of California Abundant extracellular product vaccines and methods for their production and use
AU1097795A (en) 1993-11-23 1995-06-13 Regents Of The University Of California, The Abundant extracellular products and methods for their production and use
US5714593A (en) * 1995-02-01 1998-02-03 Institut Pasteur DNA from mycobacterium tuberculosis which codes for a 45/47 kilodalton protein
US20050033022A1 (en) * 1997-09-26 2005-02-10 Smithkline Beecham Biologicals Sa Fusion proteins comprising HIV-1 Tat and/or Nef proteins
WO1999045119A2 (fr) * 1998-03-06 1999-09-10 Statens Serum Institut Fabrication de polypeptides mycobacteriens par une bacterie d'acide lactique
EP1087788A1 (fr) * 1998-06-26 2001-04-04 Aventis Pasteur Immunisation a ciblage mucosal
US7431919B2 (en) * 2003-08-20 2008-10-07 Avon Products, Inc Mascara composition

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4348280A (en) * 1974-10-21 1982-09-07 Baxter Travenol Laboratories, Inc. Proportioning dialysis machine
US4153556A (en) * 1977-12-28 1979-05-08 Uop Inc. Method and apparatus for conditioning demineralized water
US4619828A (en) * 1982-07-06 1986-10-28 Connaught Laboratories, Inc. Polysaccharide exotoxoid conjugate vaccines
DE3243817C2 (de) * 1982-11-26 1986-01-02 Hager & Elsässer GmbH, 7000 Stuttgart Verfahren zur Erzeugung von keimarmem Reinwasser
US4574049B1 (en) * 1984-06-04 1999-02-02 Ionpure Filter Us Inc Reverse osmosis system
US4595498A (en) * 1984-12-27 1986-06-17 Thomson Components-Mostek Corporation Water-polishing loop
US4626346A (en) * 1986-02-10 1986-12-02 Hall Belton E Reverse osmosis water purification system for use in limited water supply installations
US4876193A (en) * 1986-02-24 1989-10-24 Imreg, Inc. (Delaware Corporation) Determination of suppressor functional reserve
JPS6380804A (ja) * 1986-09-24 1988-04-11 Toray Ind Inc 膜分離システムの処理方法
US4787980A (en) * 1986-10-01 1988-11-29 Monsanto Company Ultra pure water system monitoring
US4770770A (en) * 1987-09-28 1988-09-13 Everpure, Inc. Water supply system using reverse osmosis unit for treatment of water supply

Also Published As

Publication number Publication date
EP0632816A1 (fr) 1995-01-11
WO1993019093A1 (fr) 1993-09-30
US5599541A (en) 1997-02-04
FR2688785A1 (fr) 1993-09-24
CA2132218A1 (fr) 1993-09-30

Similar Documents

Publication Publication Date Title
EP0586019A3 (fr) Dispositif suiveur de cible et caméra le comprenant.
EP0599979A4 (fr) Peptide meta-amyloide marque et depistage de la maladie d'alzheimer.
CA2170143A1 (fr) Regulateur de la degenerescence neuronale
HU9401260D0 (en) Fema gene of staphylococcus epidermis, fema protein, and vectors and microorganisms comprising the fema gene
EP0639925A3 (fr) Détection de vecteurs de mouvement.
MX9201416A (es) Peptidos y pseudopeptidos antitromboticos.
FR2688785B1 (fr) Sequence peptidique apte a induire une reaction d'hypersensibilite de type retarde en presence de bacteries vivantes du complexe mycobacterium tuberculosis, et ses applications.
EP0662290A3 (fr) Fermoir.
TR26973A (tr) Bacillus thuringiensis cryie geni ve lepidoptera takimindan böceklere karsi zehirli protein.
HK1001404A1 (en) Isolated, tyrosinase derived peptides and uses thereof.
ZA969402B (en) Novel oligopeptides, the preparation and use thereof.
EP0653162A4 (fr) Colletotrichum et son utilisation.
AU8526691A (en) Nucleotide and amino acid sequences of protein mtp40 of m. tuberculosis and synthetic peptides derived therefrom
FR2702014B1 (fr) Joint d'assemblage d'angle en onglet.
EP0600278A3 (fr) Protéine et gène du récepteur de glutamate.
EP0591518A4 (fr) Mecanisme melangeur et soufflant amplifie et ses utilisations.
FR2720601B1 (fr) Dégrappeuse à moules et autres coquillages.
Warnecke Burial societies, African religion and the Church.
ZA9610510B (en) Novel peptides, the preparation and use thereof.
Pepper The effects of goal specificity, goal difficulty and goal source on endurance performance
Pelucchi Etiquetage et normalisation des $ K^{0} $ et $\overline {K^{0}} $ dans l'expérience CPLEAR
Sangal The effects of incest on matrimonial consent.
Xu Representations of locally compact groups, amenability and compactifications
Settles Minutes of the QCD Meetings on 8 March and 12 April 1995
Lee The School Culture and Personal Teaching Efficacy

Legal Events

Date Code Title Description
ST Notification of lapse